78 Participants Needed

Reduced-dose Radiotherapy for Neuroblastoma

SW
Brian Kushner, MD profile photo
Overseen ByBrian Kushner, MD
Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: Memorial Sloan Kettering Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The purpose of this study is to give 12T a smaller dose of radiation in order to decrease these late side effects.

Who Is on the Research Team?

SW

Suzanne Wolden, MD

Principal Investigator

Memorial Sloan Kettering Cancer Center

Are You a Good Fit for This Trial?

This trial is for children and young adults (1 month to 18 years old) with high-risk neuroblastoma who've had chemotherapy and surgery. They must not be pregnant, breastfeeding, or have any leftover large tumors after surgery. If they can have children, they need to use birth control and have a negative pregnancy test before starting.

Inclusion Criteria

I have stage 3 neuroblastoma with MYCN amplification or I am over 18 months old with unfavorable pathology.
My diagnosis of neuroblastoma has been confirmed by a specialist.
I am a woman who can have children and have a recent negative pregnancy test.
See 8 more

Exclusion Criteria

I still have visible tumor after surgery.
Patients with any concurrent medical or psychiatric condition or disease which, in the investigator's judgment, would make them inappropriate candidates for entry into this study.
I have had radiation therapy on or near where my tumor was located.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Radiation

Patients undergo external beam radiation therapy using IMRT or proton beam RT twice daily for 5-6 weekdays (10-12 treatments)

1-2 weeks
10-12 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment, with evaluations at 6, 12, 18, and 24 months

24 months
4 visits (in-person)

Long-term follow-up

Event-free survival and assessment of toxicity will be monitored over 3 years

3 years

What Are the Treatments Tested in This Trial?

Interventions

  • External Beam Radiotherapy
  • Proton Beam RT
Trial Overview The study tests whether using a lower dose of radiation therapy (proton beam RT or external beam radiotherapy) can effectively treat neuroblastoma while reducing long-term side effects from the treatment.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: patients with high-risk neuroblastomaExperimental Treatment2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Memorial Sloan Kettering Cancer Center

Lead Sponsor

Trials
1,998
Recruited
602,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security